Atlas Trials

Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B

Clinical trial NCT01906580 · UNKNOWN

Trial details

NCT number
NCT01906580
Sponsor
Beijing 302 Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2011-07-01
Primary completion
2016-07-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.